Skip to content

Diets With a Spectrum of Fat Intake for Preventing Obesity: A Randomized Controlled-feeding Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02355795
Enrollment
307
Registered
2015-02-04
Start date
2014-11-30
Completion date
Unknown
Last updated
2016-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

weight change, diet, dietary fat, feeding design

Brief summary

The aim of the current study is to evaluate the effects of diets with three levels of dietary fat on weight change and related cardiometabolic risk factors in a 6-month randomized controlled-feeding trial.

Interventions

BEHAVIORALlow-fat diet

Energy from total fat, protein and carbohydrates are 20%, 14% and 66%, respectively

BEHAVIORALmoderate-fat diet

Energy from total fat, protein and carbohydrates are 30%, 14% and 56%, respectively

BEHAVIORALhigh-fat diet

Energy from total fat, protein and carbohydrates are 40%, 14% and 46%, respectively

Sponsors

National Basic Research Program, China
CollaboratorOTHER
National Natural Science Foundation of China
CollaboratorOTHER_GOV
Chinese PLA General Hospital
CollaboratorOTHER
Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Students in Zhejiang University or working stuff in the Chinese PLA General Hospital * 18 ≤ age ≤ 35 * Body Mass Index \< 28\* * Are willing to eat all of the study foods even when full * Are willing to eat only foods provided * Are willing to avoid strenuous activity during the 6-mo intervention

Exclusion criteria

: * Systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg * Total cholesterol ≥ 239 mg/dL * Low-density lipoprotein cholesterol ≥ 159 mg/dL * Triglycerides ≥ 199 mg/dL * Blood glucose ≥ 110 mg/dL * Change in body weight exceeding ± 10% during the prior year * Energy intake is too low or too high * Unwillingness or special requirement for diet that could not be modified * Poor adherence during the recruiting meeting or unsatisfactory completion of keeping food diary or filling questionnaire at any time before randomization * Eating disorder or any psychosocial or scheduling factors that could impede study outcomes * Have a history of diagnosed CVD, diabetes, cancer or inflammatory diseases * Have a history of a mental illness * Have diagnosed endocrine, pulmonary or hematological disease * Have diagnosed bowel disease or malabsorption that would prevent the participants from complying with the dietary restrictions of the feeding trial * Renal or liver insufficiency * Other chronic disease thought to interfere with the effect of the diet or with participation or adherence * Current use of supplements or anti-inflammation medications or medications affecting glucose, lipid metabolism and blood pressure * Smoking or alcoholic beverage intake \>1 times per week * Current or planned pregnancy prior to end of study, or breast-feeding * Irregular menstrual cycles * Have birth control medication

Design outcomes

Primary

MeasureTime frameDescription
body weight in kilograms as measured by a calibrated scale0,1,2,3,4,5,and 6 monthschange from baseline will be reported

Secondary

MeasureTime frameDescription
waist circumference as measured by an anthropometric measuring tape0,1,2,3,4,5,and 6 monthschange from baseline will be reported
blood pressure as measured by a validated automated sphygmomanometer0,1,2,3,4,5,and 6 monthschange from baseline will be reported
fasting blood lipids as measured by a clinical chemistry analyzer0,1,2,3,4,5,and 6 monthschange from baseline will be reported
fasting glucose, insulin, glycated serum protein as measured by an immunology analyzer0,1,2,3,4,5,and 6 monthschange from baseline will be reported
adiponectin, leptin as measured by ELISA kits0,1,2,3,4,5,and 6 monthschange from baseline will be reported

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026